New technology available at The James means pathology experts studying bladder cancer tissue now have an additional layer of diagnostic capabilities – enabling the urologic oncologists to identify additional treatment strategies specifically for these patients. Dr. Cheryl Lee, chair of the Department of Urology, discusses.